DynamicOrgan System: Open Organ-on-Chip Platform Demo

Added:

Systemic Complexity and Translational Limitations of Organ-on-Chip Models

While open organ-on-chip (OoC) platforms like the DynamicOrgan System offer advanced in vitro modeling, critics argue they cannot fully replicate the systemic complexity of a living organism. A major limitation of OoC technology is its inability to simulate whole-body interactions, such as complex immune responses, multi-organ endocrine feedback loops, and systemic drug pharmacokinetics and pharmacodynamics (PK/PD). Consequently, while OoC is valuable for mechanistic studies, it cannot completely replace in vivo animal testing, which remains essential for capturing systemic physiological responses. Furthermore, the high customization of open platforms can lead to issues with standardization and reproducibility, making it difficult to achieve the high-throughput efficiency and regulatory validation required for drug approval.

Fundamentals of Microfluidics: Understanding fluid behavior at the micro-scale, including laminar flow, shear stress, and diffusion.
In Vitro vs. In Vivo Modeling: Grasping the differences between traditional 2D cell cultures, animal models, and the need for more physiologically relevant human cell-based models.
Basic Cell Biology and Tissue Engineering: Knowledge of cell culture techniques, co-culturing different cell types, and the role of the extracellular matrix (ECM) in maintaining cell phenotype.
Introduction to Biochip Materials: Familiarity with biomaterials commonly used in microfluidic devices, such as PDMS, PMMA, and other biocompatible polymers.
Disease Modeling Applications: Exploring how to recapitulate specific pathophysiological conditions, such as tumor microenvironments or blood-brain barrier disruption, using organ-on-chip platforms.
Multi-Organ-on-Chip (Body-on-a-Chip): Studying the integration of multiple organ models in series to analyze systemic drug absorption, distribution, metabolism, and excretion (ADME).
High-Throughput Screening (HTS): Investigating how organ-on-chip systems can be automated and scaled for rapid drug discovery and toxicity testing.
Regulatory Science and Translation: Examining the validation standards, regulatory hurdles (such as FDA modernization initiatives), and ethical considerations for replacing animal testing with microphysiological systems.
649 views3likes4:44@Dynamic42Original Release: 2025-03-25

The Dynamic Organ System is an open organ-on-chip platform consisting of a pump, biochips with dual chambers separated by porous membranes, reservoirs, tubing, and connectors. Each biochip contains two interconnected chambers (left and right) with top and bottom channels separated by a porous membrane, enabling the creation of complex organ models like vasculature and epithelium. The setup process involves attaching plugs to close static sites, connecting reservoirs to the biochip via ports, and linking tubing to both the biochip and reservoir lids. The complete workflow includes biochip stabilization with ethanol, membrane coating, cell seeding at appropriate concentrations, incubation until confluence, and finally connecting the perfusion equipment to the pump for medium perfusion. This system allows researchers to build human in vitro disease and infection models using standard laboratory equipment without capital spending.